Share chart Illumina
Extended chart
Simple chart
About Illumina
Компания Illumina, Inc., основана в апреле 1998 года, занимается разработкой, производством и внедрением систем анализа генетического разнообразия и биологических функций. Illumina производит линейку продуктов и услуг для секвенирования, генотипирования и изучения экспрессии генов.IPO date | 2000-07-28 |
---|---|
ISIN | US4523271090 |
Industry | Life Sciences Tools & Services |
Sector | Health Care |
Валюта | usd |
Валюта отчета | usd |
Сайт | http://www.illumina.com |
Цена ао | 81.57 |
Change price per day: | 0% (81.57) |
---|---|
Change price per week: | +9.45% (74.53) |
Change price per month: | +9.08% (74.78) |
Change price per 3 month: | -18.98% (100.68) |
Change price per half year: | -44.2% (146.17) |
Change price per year: | -29.43% (115.58) |
Change price per 3 year: | -65.29% (235) |
Change price per 5 year: | -78.34% (376.53) |
Change price per 10 year: | -50.99% (166.42) |
Change price per year to date: | -38.96% (133.63) |
|
Underestimation
|
Efficiency
|
|||||||||||||||||||||||||||||||||||||
Dividends
|
Debt
|
Growth impulse
|
Dividend, % | Dividend | Result of period | Buy before | Register closing date | Payment before |
---|---|---|---|---|---|
3.81% | 3.104 | I кв. 2024 | 21.06.2024 | 25.06.2024 | 10.07.2024 |
Transaction date | Date of disclosure | Insider | Type | Price | Volume | Quantity | Share before, % | Share after, % | Document |
---|---|---|---|---|---|---|---|---|---|
22.06.2023 | 26.06.2023 | TOUSI SUSAN H SVP, Chief Commercial Officer |
Sale | 200 | 100 000 | 500 | 0 | 0 | link |
22.02.2023 | 23.02.2023 | Aravanis Alexander SVP, Chief Technology Officer |
Sale | 201.74 | 1 088 990 | 5398 | 0 | 0 | link |
21.02.2023 | 23.02.2023 | Aravanis Alexander SVP, Chief Technology Officer |
Purchase | 202.2 | 1 878 840 | 9292 | 0 | 0.01 | link |
28.03.2022 | 30.03.2022 | Dadswell Charles SVP & General Counsel |
Sale | 342.83 | 126 161 | 368 | 0 | 0 | link |
30.08.2021 | 01.09.2021 | TOUSI SUSAN H SVP, Chief Commercial Officer |
Sale | 463.5 | 139 050 | 300 | 0 | 0 | link |
22.04.2021 | 26.04.2021 | Dadswell Charles SVP & General Counsel |
Sale | 402.02 | 126 234 | 314 | 0 | 0 | link |
15.12.2020 | 16.12.2020 | FLATLEY JAY T Director |
Sale | 348.84 | 1 395 360 | 4000 | 0 | 0 | link |
14.12.2020 | 16.12.2020 | Hoyt Aimee L SVP, Chief People Officer |
Sale | 345 | 122 130 | 354 | 0 | 0 | link |
Institutions | Volume | Share, % |
---|---|---|
Vanguard Group Inc | 18178513 | 11.41 |
Blackrock Inc. | 13302999 | 8.35 |
Edgewood Management Llc | 6878495 | 4.32 |
State Street Corporation | 6723616 | 4.22 |
Baillie Gifford and Company | 5275769 | 3.31 |
Loomis Sayles & Company, LP | 4424688 | 2.78 |
Janus Henderson Group PLC | 4402380 | 2.76 |
Morgan Stanley | 3698229 | 2.32 |
Geode Capital Management, LLC | 3634176 | 2.28 |
Wellington Management Group, LLP | 3239021 | 2.03 |
ETF | Share, % | Profitability for 1 year, % | Dividends, % |
---|---|---|---|
Global X Telemedicine & Digital Health ETF Registered | 4.01425 | 12.78 | 0.28226 |
Future Tech ETF | 2.02764 | 426.34 | 0.8416 |
Principal Healthcare Innovators ETF | 2.02764 | 618.5 | 0.8416 |
IQ Engender Equality ETF | 1.49781 | 30.64 | 1.74017 |
Pacer BioThreat Strategy ETF | 0.71622 | 14.04 | 1.65371 |
Syntax Stratified MidCap ETF | 0.45703 | 17.66 | 1.56212 |
iShares Morningstar Mid-Cap Growth ETF | 0.38685 | 9.66 | 0.94237 |
iShares Morningstar Mid-Cap ETF | 0.19271 | 5.2 | 1.7458 |
Nationwide Nasdaq-100 Risk-Managed Income ETF | 0.14325 | 21.38 | 0.87606 |
iShares Morningstar Large-Cap Growth ETF | 0.08548 | 12.73 | 0.5823 |
iShares Morningstar Large-Cap ETF | 0.04135 | 257.57 | 1.41244 |
JPMorgan U.S. Aggregate Bond ETF | 0.03 | 2.4 | 1.33 |
Columbia U.S. ESG Equity Income ETF | 0.02743 | -99.18 | 1.44131 |
Head | Job title | Payment | Year of birth |
---|---|---|---|
Stephanie Campos | President | N/A | |
Mr. Charles E. Dadswell Esq. | Senior VP & General Counsel | 1.06M | 1959 (66 years) |
Ms. Carissa L. Rollins | Chief Information Officer | N/A | 1970 (55 years) |
Dr. Steven Barnard Ph.D. | Chief Technology Officer | N/A | |
Ms. Sallilyn Schwartz | Vice President of Investor Relations | N/A | |
Mr. Jacob Thaysen Ph.D. | CEO & Director | N/A | 1975 (50 years) |
Mr. Ankur Dhingra | Chief Financial Officer | 1976 (49 years) | |
Mr. Kevin Carl Pegels | Chief of Global Operations | 1968 (57 years) | |
Mr. Scott Ericksen | VP & Chief Accounting Officer | 1973 (52 years) | |
Mr. Jakob Wedel | Chief Strategy & Corporate Development Officer and CEO Chief of Staff |
Address: United States, San Diego, 5200 Illumina Way - open in Google maps, open in Yandex maps
Website: http://www.illumina.com
Website: http://www.illumina.com